Juno Therapeutics Inc. (JUNO) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Juno Therapeutics Inc. (JUNO)

JUNO 86.96

0.0%

Mar 6 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: scaram(o)uche	9/26/2016 5:07:21 PM
	of 84

kite top line looks very good. Lots of twitter chatter about erosion of CR rate, but company points to earlier trials (phase I and NCI) indicating that relapse rates stabilize beyond 3 months. Note that those were small trials, so enthusiasm could be misplaced. Management also feels that toxicities (marked) were well managed with room for improvement. We'll see what 6 month results look like, eh?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next